Chapter 1 Toxin-Based Rodent Rodents Models of Parkinson’s Disease Parkinson’s disease (PD)

Chapter 2 Assessment of Nonmotor Symptoms in Rodent Rodents Models of Parkinson’s Disease Parkinson’s disease (PD)

Chapter 4 A Review of Randomized Phase III Phase III Pharmacological Clinical Trials Clinical trials for Motor Symptoms Motor symptoms in Parkinson’s Disease Parkinson’s disease (PD) Patients and Quality of Evidence Quality of evidence Recommendations

Chapter 5 Clinical Trials for Motor Complications Motor complications in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 6 Clinical Trials Clinical trials for Gait Gait Disorders in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 7 Clinical Trials Clinical trials for Disease-Modifying Agents in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 8 Value and Methods of Pharmacovigilance Pharmacovigilance in the Monitoring of Drug Safety Drug safety in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 9 Clinical Trials Clinical trials for Cognitive Impairment and Dementia in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 10 Clinical Trials Clinical trials for Depression Depression , Anxiety Anxiety , Fatigue Fatigue , and Apathy Apathy in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 11 Clinical Trials Clinical trials for Sleep Disorders Sleep disorders and Daytime Somnolence Somnolence in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 12 Clinical Trials Clinical trials on Management of Pain Pains in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 13 Clinical Trials Clinical trials for Orthostatic Hypotension Orthostatic hypotension (OH) in Parkinson’s Disease Parkinson’s disease (PD) and Other Synucleinopathies Synucleinopathies

Chapter 14 Clinical Trials Clinical trials for Erectile Dysfunction Erectile dysfunction in Parkinson’s Disease Parkinson’s disease (PD)

Chapter 15 Clinical Trials Clinical trials for Constipation Constipation in Parkinson’s Disease Parkinson’s disease (PD)